11/30/2015 - 12:54pm

Takeda’s Ninlaro is a treatment for patients with multiple myeloma who have had at least one prior therapy. 

11/30/2015 - 12:17pm

Approximately 35% received the flu shot at a doctor’s office, followed by 27% who received it at a pharmacy. 

11/25/2015 - 10:37am

Novartis’ Fluad is a trivalent flu vaccine that contains the adjuvant MF59, an emulsion of squalene oil in water, and is aimed at improving immune response among patients 65 years of age and older. 

11/24/2015 - 1:31pm

Eli Lilly and Co.’s Petrazza in a trial extended the lives of patients who took the drug in combination with two forms of chemotherapy to 11.5 months. 

11/24/2015 - 10:47am

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

11/23/2015 - 4:10pm

The FDA has approved Bristol-Myers Squibb’s Opdivo as a treatment for renal cell carcinoma in some patients. 

11/23/2015 - 3:26pm

CVS Health has opted to only offer one of the two new PCSK9 inhibitors on its CVS/caremark commercial formularies. 

11/23/2015 - 2:57pm

The new indication provides another option for the estimated 300,000 patients who will undergo hip replacements in a year. 

11/23/2015 - 1:30pm

Perrigo is buying a Crohn’s disease treatment from AstraZeneca.